NDC 0009-3124

Cleocin Phosphate 150 mg per 1 mL injection, solution

Where it's made

Factory	Where	Role	Last FDA inspection
Pharmacia & Upjohn Company LLC	Kalamazoo, MI, United States	Makes it, makes the active ingredient, tests it, packages it and labels it	Problems found, fixed voluntarilyJun 16, 2023 · 9 inspections

Mar 15, 2019 · Class III · Pfizer Inc.
Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point
Lots: Lot #: T97469, Exp. 7/2019, W28574, Exp.09/2019
Mar 15, 2019 · Class III · Pfizer Inc.
Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point
Lots: Lot#: T78191, Exp.04/2019, T97494, Exp.07/2019
Mar 15, 2019 · Class III · Pfizer Inc.
Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point
Lots: Lot #: T78193, Exp.04/2019
Jun 4, 2013 · Class II · Pharmacia & Upjohn LLC
Presence of Particulate Matter: Firm is recalling a small number of vials with very small reflective flakes consistent with delamination of the glass vial.
Lots: Lots: a) G34908, Exp 06/14; G53479, Exp 09/14; G63442, G58347, Exp 10/14; G80133, Exp 12/14; and b) G34910, Exp 06/14; G36879, G41005, Exp 07/14; G53478, Exp 09/14; G63444, Exp 10/14; G76317, Exp 11/14.

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Generic drug: Clindamycin: every company that makes it
Form: injection, solution
Strength: 150 mg per 1 mL
Approval: ANDA ANDA062803
On the market since: Oct 16, 1987
Package NDCs: 0009-3124-01 0009-3124-03
Official label: DailyMed (National Library of Medicine), updated Jul 29, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?